Indivior loses another case in battle to protect opioid addiction drug
(Reuters) - Shares in Britain's Indivior were hammered on Friday after it lost a second legal case in recent months in its battle to protect the patent of its opioid addiction treatment that generates 80 percent of its revenues.
from Reuters: Health News http://reut.rs/2pBkNg5
http://bit.ly/2zwRqiM